Resultados de Búsqueda por Autor

artículo

Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries

Publicado por
Demichelis-Gómez, R, Alvarado-Ibarra, M, Vasquez-Chávez, J, Delgado-López, N, Gómez-Cortés, C, Espinosa-Bautista, K, Cooke-Tapia, A, Milán-Salvatierra, A, Gómez-De León, A, Lee-Tsai, YL, Rosales-López, D, Cabrera-García, Á, Amador-Medina, F, Córdoba-Ramírez, A, Murrieta-Álvarez, I, Solís-Poblano, JC, Apodaca-Chávez, E, Rangel-Patiño, J, Álvarez-Vera, JL, Arana-Luna, L, De la Peña-Celaya, JA, Espitia-Ríos, ME, Hernández-Ruiz, E, Pérez-Zúñiga, JM, Peña-López, E, González-Rivera, R, García-Leyva, MF, Tejeda-Romero, M, Cruz-Rico, J, Balderas-Delgado, C, Ruíz-Argüelles, GJ, Gómez-Almaguer, D

Publicado 2021

Enlace

Purpose: The COVID-19 pandemic is a colossal challenge for global health; nonetheless, specific subgroups face considerably higher risks for infection and mortality. Among patients with malignant diseases, those with hematologic neoplasms are at a higher risk for poor outcomes. The objective of this study was to register treatment modifications associated with the COVID-19 pandemic and their short-term consequences in Latin America. Methods: Multicenter, prospective, observational, cohort study including patients older than 14 years from 14 centers in four countries (Mexico, Peru, Guatemala, and Panama) who had a confirmed diagnosis of acute leukemia, and who were undergoing active treatment since the first COVID-19 case in each country until the cutoff on July 15, 2020. Results: We recruited 635 patients. Treatment modifications because of the COVID-19 pandemic were reported in 40.8% of...

artículo

Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries

Publicado 2021

Enlace

Purpose: The COVID-19 pandemic is a colossal challenge for global health; nonetheless, specific subgroups face considerably higher risks for infection and mortality. Among patients with malignant diseases, those with hematologic neoplasms are at a higher risk for poor outcomes. The objective of this study was to register treatment modifications associated with the COVID-19 pandemic and their short-term consequences in Latin America.Methods: Multicenter, prospective, observational, cohort study including patients older than 14 years from 14 centers in four countries (Mexico, Peru, Guatemala, and Panama) who had a confirmed diagnosis of acute leukemia, and who were undergoing active treatment since the first COVID-19 case in each country until the cutoff on July 15, 2020.Results: We recruited 635 patients. Treatment modifications because of the COVID-19 pandemic were reported in 40.8% of c...